Italy Regenerative Dentistry Market Size and Forecast 2021 - 2031, Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Technology, Application, Age Group, and End User

Description

List of Tables

The Italy Regenerative Dentistry Market is expected to reach US$ 137.90 million by 2031 from US$ 92.02 million in 2024; the market is estimated to grow at a CAGR of 6.0% during 2025-2031. Major factors driving the market growth include Increasing geriatric population, growing burden of dental diseases, and rising demand for cosmetic dentistry are likely to boost the market during the forecast period. However, the high cost of dental regeneration treatment hampers the market growth.

Dental diseases are among the most preventable public health concerns reported in Italy. According to Eurostat data, Italy is the oldest country in the European Union, with an average median age exceeding 48 years. Along with Portugal, Italy has the highest percentage of residents aged over 65, accounting for 24% of the population-approximately one in four individuals. In January 2023, the Italian Institute for International Political Studies published an article titled "The Not-So-Sweet Life of Italy's Elders" highlighting the fastest population aging in Italy after Japan and South Korea. In 2022, there were 37 individuals aged over 65 for every 100 working-age people (aged 15-64), and this ratio is expected to rise to 65 by 2050. During the same period, the percentage of people over 80 will increase from 3.7% to 7.5%. Edentulism, or complete tooth loss, and severe tooth loss are becoming increasingly common, particularly among older populations. The prevalence of dental caries and periodontal diseases has surged, leading to the adoption of advanced regenerative therapies, such as stem cell-based treatments and tissue engineering. These minimally invasive techniques are gaining popularity due to their ability to reduce pain and recovery time while effectively restoring dental tissues.

Dental diseases are a significant factor contributing to market growth in Italy. As per the study titled "Experience and Prevalence of Dental Caries in Migrant and Nonmigrant Low-SES Families' Children Aged 3 to 5 Years in Italy," published in September 2022, dental caries is predominant among children from low socioeconomic status groups and the prevalence of caries was found to be 71% among these children. The demand for dental care solutions to address tooth loss, periodontal disease, and other age-related oral health issues is increasing, especially among the aging demographics. Treatments focusing on gum tissue regeneration, bone regeneration, and tooth pulp therapy are particularly appealing as they provide less invasive alternatives to traditional options like implants and dentures.

As a result, regenerative medicine technologies, such as stem cell-based treatments and biocompatible scaffolds, are offering effective solutions for cosmetic and restorative dental needs.

The comparative company analysis evaluates and categorizes the Italy Regenerative Dentistry Market based on product portfolio (Product Type, Technology, Application, Age Group, and End User), recent market developments (merger & acquisition, new product launch & enhancement, investment & funding, award, agreement, collaboration, & partnership, recognition, and expansion), and geographic presence that aids better decision-making and understanding of the competitive landscape. The report profoundly explores the recent significant developments and innovations by the leading vendors in the Italy Regenerative Dentistry Market. The key market players are Dentsply Sirona Inc, Geistlich Pharma AG, Evonik Industries AG, ZimVie Inc, BioHorizons Inc, Nobel Biocare Services AG, UBGEN, B&B Dental Implant Company, Botiss Biomaterials GmbH, Envista Holdings Corporation

Based on Technology, the Italy Regenerative Dentistry Market is segmented into Tissue Engineering, Stem Cell Therapy, and Others. In 2024, the Tissue Engineering, segment held the largest share of the market. Based on Application, the Italy Regenerative Dentistry Market is segmented into Periodontal Regeneration, Endodontic Regeneration, Tooth Reconstruction, Bone Regeneration, and Others. In 2024, the Periodontal segment held the largest share of the market.

Various organic and inorganic strategies are adopted by companies operating in the Italy Regenerative Dentistry Market. The organic strategies mainly include product launches and product approvals. Inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, along with contributing to the overall market growth. Furthermore, strategies such as acquisitions and partnerships helped strengthen their customer base and extend their product portfolios. A few of the significant developments by key players in the Italy Regenerative Dentistry Market are listed below.

In July 2022, Evonik's recombinant, non-animal-derived collagen platform is now available at commercial scale. Vecollan is highly pure and soluble collagen that is produced via fermentation. It features a triple-helix structure to mimic the properties of natural collagen, making it suitable for use in medical, pharmaceutical, cell culture, tissue, and other life science applications

Product Code: TIPRE00040909

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Italy Regenerative Dentistry Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Italy Regenerative Dentistry Market - Key Market Dynamics

5.1 Italy Regenerative Dentistry Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Geriatric Population and Growing Burden of Dental Diseases
- 5.2.2 Rising Demand for Cosmetic Dentistry
5.3 Market Restraints
- 5.3.1 High Cost of Dental Regeneration Treatment
5.4 Market Opportunities
- 5.4.1 Technological Advancements
5.5 Future Trends
- 5.5.1 Increased Adoption of Stem Cell Therapy
5.6 Impact of Drivers and Restraints:

6. Italy Regenerative Dentistry Market Analysis

6.1 Italy Regenerative Dentistry Market Revenue (US$ Million), 2021-2031
6.2 Italy Regenerative Dentistry Market Forecast and Analysis

7. Italy Regenerative Dentistry Market Analysis - by Product Type

7.1 Natural Biomaterials
- 7.1.1 Overview
- 7.1.2 Natural Biomaterials: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Synthetic Biomaterials
- 7.2.1 Overview
- 7.2.2 Synthetic Biomaterials: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)

8. Italy Regenerative Dentistry Market Analysis - by Technology

8.1 Tissue Engineering
- 8.1.1 Overview
- 8.1.2 Tissue Engineering: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Stem Cell Therapy
- 8.2.1 Overview
- 8.2.2 Stem Cell Therapy: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)

9. Italy Regenerative Dentistry Market Analysis - by Application

9.1 Periodontal Regeneration
- 9.1.1 Overview
- 9.1.2 Periodontal Regeneration: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Endodontic Regeneration
- 9.2.1 Overview
- 9.2.2 Endodontic Regeneration: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Tooth Reconstruction
- 9.3.1 Overview
- 9.3.2 Tooth Reconstruction: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Bone Regeneration
- 9.4.1 Overview
- 9.4.2 Bone Regeneration: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)

10. Italy Regenerative Dentistry Market Analysis - by Age Group

10.1 Adult
- 10.1.1 Overview
- 10.1.2 Adult: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
10.2 Pediatric
- 10.2.1 Overview
- 10.2.2 Pediatric: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)

11. Italy Regenerative Dentistry Market Analysis - by End-user

11.1 Hospitals
- 11.1.1 Overview
- 11.1.2 Hospitals: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Dental Clinics
- 11.2.1 Overview
- 11.2.2 Dental Clinics: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Others
- 11.3.1 Overview
- 11.3.2 Others: Italy Regenerative Dentistry Market - Revenue and Forecast to 2031 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 New Product Development
12.3 Partnerships
12.4 Other Business Strategies

13. Company Profiles

13.1 Dentsply Sirona Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Geistlich Pharma AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Evonik Industries AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 ZimVie Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 BioHorizons Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Nobel Biocare Services AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 UBGEN
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 B&B Dental Implant Company
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Botiss Biomaterials GmbH
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Envista Holdings Corporation
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Financial Overview
- 13.10.4 SWOT Analysis
- 13.10.5 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms